Femme et Homme
- | Pays :
- Germany
- Spain
- Italy
- Les 4 autres...
- | Organes : -
- | Spécialités : -
Extrait
This was a multi-institutional, multinational, open-label, single-arm Phase Ib/II study designed to evaluate the safety, tolerability, pharmacokinetics, and efficacy of trastuzumab emtansine (trastuzumab-MCC-DM1) administered by intravenous (IV) infusion in combination with pertuzumab in patients with human epidermal growth factor receptor-2 (HER2)-positive locally advanced or metastatic breast cancer who had previously received trastuzumab.
Critère d'inclusion
- Metastatic breast cancer